You are here: Home » Economy & Policy » News » GST
Business Standard

GST effect: Prices of major essential drugs to rise by up to 2.29%

Drug price regulator is confident that pharma industry would adopt tax system without much trouble

Press Trust of India  |  New Delhi 

An extra dose of tax on medicines

Prices of a majority of essential drugs will increase by up to 2.29 per cent when the Goods and Services Tax(GST) regime kicks in from July 1. The has fixed rate of 12 per cent on most of the essential drugs as against the current incidence of around 9 per cent.

However, some select such as will see a reduction in prices with the revising rate downwards to 5 per cent from 12 per cent proposed earlier. The National List of Essential includes the likes of Heparin, Warfarin, Diltiazem, Diazepam, Ibuprofen, Propranolol and Imatinib.

Drug price regulator National Pharmaceutical Pricing Authority(NPPA) has already notified that the revised ceiling prices of scheduled drugs, where excise duty is levied on Maximum Retail Price (MRP), will be calculated by applying a factor of 0.95905 to the existing ceiling price. This will be exclusive of applicable rates.

On the other hand, those scheduled formulations which are exempted from excise duty, their existing notified ceiling price would also be the new ceiling price, exclusive of rates, added. In the case of non-scheduled formulations, has said that companies would have no option but to absorb the net increase if prices go up beyond the permissible limit of 10 per cent of due to increase in incidence on the implementation.

The regulator is, however, confident that the pharma industry would be in a position to adopt the new system without much teething troubles.

"I am confident that implementation will be by and large smooth and will not cause any major disruption in the availability of drugs in the country," Chairman Bhupendra Singh told PTI.

In case of those such as insulin, on which the rate has been revised downward to 5 per cent from 12 per cent proposed earlier, companies will be required to reduce the

said in case of savings due to a lower rate of tax, the benefit may be passed on to the consumers as per the anti-profiteering clause in the rules.

First Published: Tue, June 13 2017. 14:40 IST
RECOMMENDED FOR YOU